TSI News - 2012 Archive

October 10, 2012

Double-blind, placebo-controlled study reveals Peak ATP^® reduces muscle fatigue and maintains greater muscle strength during repeated sets

TSI Group, along with Metabolic Technologies, Inc. announced the release of a new Peak ATP ^® clinical study published in the JISSN...

TSI Group finalizes Yessamin, Ltd. deal and expands China base

TSI Group strengthens manufacturing and supply chain capabilities through strategic acquisition of Yessamin Health Company, Ltd.'s manufacturing facility...

New Two Year Study Finds Promising Results for Patients with Loss of Knee Cartilage Who Add TSI-Brand PUREFLEX^® Chondroitin to a Glucosamine Regimen

The study showed statistically significant reduction in joint space narrowing, a hallmark consumer knee joint issue...

TSI News - 2012 Archive RSS

TSI News - 2012 Archive

October 10, 2012

Double-blind, placebo-controlled study reveals Peak ATP^® reduces muscle fatigue and maintains greater muscle strength during repeated sets

August 16, 2012

TSI Group finalizes Yessamin, Ltd. deal and expands China base

February 18, 2012

New Two Year Study Finds Promising Results for Patients with Loss of Knee Cartilage Who Add TSI-Brand PUREFLEX^® Chondroitin to a Glucosamine Regimen

Tools

Archive

TSI News - 2012 Archive

October 10, 2012

Double-blind, placebo-controlled study reveals Peak ATP® reduces muscle fatigue and maintains greater muscle strength during repeated sets

August 16, 2012

TSI Group finalizes Yessamin, Ltd. deal and expands China base

February 18, 2012

New Two Year Study Finds Promising Results for Patients with Loss of Knee Cartilage Who Add TSI-Brand PUREFLEX® Chondroitin to a Glucosamine Regimen

Tools

Archive

Double-blind, placebo-controlled study reveals Peak ATP^® reduces muscle fatigue and maintains greater muscle strength during repeated sets

New Two Year Study Finds Promising Results for Patients with Loss of Knee Cartilage Who Add TSI-Brand PUREFLEX^® Chondroitin to a Glucosamine Regimen